ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

41 hedge funds and large institutions have $1.74M invested in Zynerba Pharmaceuticals, Inc in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$11K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$39.2K
2
+$16.2K
3
+$13K
4
TRCT
Tower Research Capital (TRC)
New York
+$5.13K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$1.87K

Top Sellers

1
-$108K
2
-$32K
3
-$23.1K
4
VF
Virtu Financial
New York
-$14K
5
HF
HRT Financial
New York
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2.44K
27
$1.73K
28
$1.5K
29
$1.49K
30
$652
31
$262
32
$114
33
$57
34
$33
35
$33
36
$17
37
$8
38
$7
39
$1
40
–
41
–
42
–
43
–
1
2